Rheonix Wins $233K NIAID Grant to Add UTI Detection to Multiplex STD Molecular Dx

The long-term goal of the project is to develop a single test for detecting an array of STDs and UTIs using Rheonix's fully automated point-of-care molecular diagnostic platform, called CARD.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.